HOME ·

TIGERMED

TIGERMED (03347.HK): Controlling Shareholders Ye Xiaoping and Cao Xiaochun Receive Warning Letter and Administrative Penalty Pre-notice Over Shareholding-change Disclosure Violations; RMB 1 Million Fine Proposed
Tags：
TIGERMED03347.HKRegulatory Investigation
2026-09-11
Tigermed (03347.HK): Has repurchased A-shares with a total consideration of approximately RMB 824 million
Tags：
TIGERMED03347.HK
2026-07-03
TIGERMED(03347.HK) will spend CNY 175.37 million to repurchase 4.44 million shares on Jun 12, 2026
Tags：
TIGERMED03347.HKShare Repurchase
2026-06-12
TIGERMED (03347.HK): Directors and Controlling Shareholders Ye Xiaoping and Cao Xiaochuan Placed Under CSRC Investigation
Tags：
TIGERMED03347.HKSenior executives under investigation
2026-05-12